Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 22


Human plasma protein N-glycosylation.

Clerc F, Reiding KR, Jansen BC, Kammeijer GS, Bondt A, Wuhrer M.

Glycoconj J. 2016 Jun;33(3):309-43. doi: 10.1007/s10719-015-9626-2. Epub 2015 Nov 10.


Ligand-dependent enhancement of human antithrombin gene expression by retinoid X receptor alpha and thyroid hormone receptor beta.

Niessen RW, Rezaee F, Reitsma PH, Peters M, de Vijlder JJ, Sturk A.

Biochem J. 1996 Aug 15;318 ( Pt 1):263-70.


Molecular cloning of a serine proteinase inhibitor from Brugia malayi.

Yenbutr P, Scott AL.

Infect Immun. 1995 May;63(5):1745-53.


Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.

Koide T, Odani S, Takahashi K, Ono T, Sakuragawa N.

Proc Natl Acad Sci U S A. 1984 Jan;81(2):289-93.


Compilation of published signal sequences.

Watson ME.

Nucleic Acids Res. 1984 Jul 11;12(13):5145-64. Review. No abstract available.


Arginine residues are critical for the heparin-cofactor activity of antithrombin III.

Jorgensen AM, Borders CL Jr, Fish WW.

Biochem J. 1985 Oct 1;231(1):59-63.


Modified oligonucleotides as alternatives to the synthesis of mixed probes for the screening of cDNA libraries.

Huynh-Dinh T, Duchange N, Zakin MM, Lemarchand A, Igolen J.

Proc Natl Acad Sci U S A. 1985 Nov;82(22):7510-4.


Inhibition of chymotrypsin by heparin cofactor II.

Church FC, Noyes CM, Griffith MJ.

Proc Natl Acad Sci U S A. 1985 Oct;82(19):6431-4.


Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX.

McGraw RA, Davis LM, Noyes CM, Lundblad RL, Roberts HR, Graham JB, Stafford DW.

Proc Natl Acad Sci U S A. 1985 May;82(9):2847-51.


A fragment of antithrombin that binds both heparin and thrombin.

Rosenfeld L, Danishefsky I.

Biochem J. 1986 Aug 1;237(3):639-46.


GT to AT transition at a splice donor site causes skipping of the preceding exon in phenylketonuria.

Marvit J, DiLella AG, Brayton K, Ledley FD, Robson KJ, Woo SL.

Nucleic Acids Res. 1987 Jul 24;15(14):5613-28.


Expression of functionally active human antithrombin III.

Stephens AW, Siddiqui A, Hirs CH.

Proc Natl Acad Sci U S A. 1987 Jun;84(11):3886-90.


Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor.

Antalis TM, Clark MA, Barnes T, Lehrbach PR, Devine PL, Schevzov G, Goss NH, Stephens RW, Tolstoshev P.

Proc Natl Acad Sci U S A. 1988 Feb;85(4):985-9.


Molecular cloning and chromosomal localization of human 4-beta-galactosyltransferase.

Humphreys-Beher MG, Bunnell B, vanTuinen P, Ledbetter DH, Kidd VJ.

Proc Natl Acad Sci U S A. 1986 Dec;83(23):8918-22. Erratum in: Proc Natl Acad Sci U S A 1989 Nov;86(22):8747.


Complete amino acid sequence of human thyroxine-binding globulin deduced from cloned DNA: close homology to the serine antiproteases.

Flink IL, Bailey TJ, Gustafson TA, Markham BE, Morkin E.

Proc Natl Acad Sci U S A. 1986 Oct;83(20):7708-12.


Chromosome I linkage studies in Charcot-Marie-Tooth neuropathy type I.

Griffiths LR, Zwi MB, McLeod JG, Nicholson GA.

Am J Hum Genet. 1988 May;42(5):756-71.


Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.

Molho-Sabatier P, Aiach M, Gaillard I, Fiessinger JN, Fischer AM, Chadeuf G, Clauser E.

J Clin Invest. 1989 Oct;84(4):1236-42.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk